Daniel Brenner, MD
Interventional Cardiology · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 14
Offices
14 locations · Sutter Bay Medical Foundation · Sutter Bay Hospitals
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus · Sutter Lakeside Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Brenner’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A105376 · Current
Licensed to practise in California · since 2008 · expires 2026-09-30 · Boston University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Sutter Lakeside HospitalLakeport, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Sutter Lakeside Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 8.7 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 133 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 379 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 31 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.249 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -25.4 · 92 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -37.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 109 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.3) · 564 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 52 cases | No different | Jan 2024 – Dec 2024 |
What patients said (209 patients answered, 18% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 58% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$334,509
Medicare paid this office $334,509 for 1,505 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 551 | $57,854 | $93 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 76 | $29,830 | $392 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 120 | $22,843 | $181 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 34 | $18,987 | $396 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 303 | $16,947 | $51 |
See all 44 services
| Return visit (30+ min) | 551 | $57,854 | $93 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 76 | $29,830 | $392 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 120 | $22,843 | $181 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 34 | $18,987 | $396 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 303 | $16,947 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $12,912 | $95 |
| New patient visit (45+ min) | 92 | $11,996 | $130 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 77 | $11,480 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $11,123 | $139 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 16 | $9,509 | $84 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 673 | $8,502 | $11 |
| Critical care, first 30-74 minutes | 37 | $8,485 | $170 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 26 | $7,077 | $272 |
| Transitional care management services for problem of at least moderate complexity | 36 | $6,747 | $182 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 17 | $6,693 | $394 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 447 | $6,407 | $13 |
| Long return visit (40+ min) | 37 | $5,594 | $147 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 112 | $5,235 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 90 | $4,845 | $21 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 72 | $4,143 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 62 | $3,423 | $55 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 45 | $3,375 | $73 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 24 | $3,215 | $134 |
| Programming of dual lead pacemaker system | 37 | $3,030 | $66 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 50 | $2,972 | $58 |
| External shock to heart to regulate heart beat | 33 | $2,945 | $87 |
| Remote monitoring of pulmonary artery pressure sensor, up to 30 days | 12 | $2,717 | $45 |
| Transitional care management services for problem of high complexity | 11 | $2,713 | $247 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $2,453 | $88 |
| New patient visit (60+ min) | 11 | $2,038 | $185 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 190 | $1,968 | $10 |
| Ultrasound of heart with probe in esophagus, with report | 21 | $1,818 | $87 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 22 | $1,800 | $26 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | 27 | $1,423 | $41 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 54 | $1,010 | $19 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 11 | $701 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 106 | $497 | $5 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 14 | $405 | $29 |
| Injection, regadenoson, 0.1 mg | 19 | $319 | None |
| Ultrasound of heart, follow-up | 15 | $302 | $19 |
| Heart rhythm recording of continous external ekg over 8-15 days | 24 | $262 | $11 |
| Heart muscle strain imaging | 31 | $251 | $8 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $233 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $58 | $3 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 54 | More than 84% of doctors who do this |
| Pacemaker insertion or repair | 19 | More than 70% of doctors who do this |
Who their Medicare patients are
1,505 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 15% · Women 48% · Also on Medicaid 24% · Health risk score 1.57. At or below the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 53% · Atrial fibrillation 38% · Heart failure 37% · Chronic kidney disease 32% · Diabetes 31% · COPD 21% · Depression 19% · Cancer 14% · Stroke 11% · Dementia 6%.
The office billed $2,057,535, Medicare allowed $449,794 and paid $334,509; for 5,057 services of 91 kinds; $319 of it was for drugs given in the office and $334,189 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,505 | 5,057 | 76 | 1.57 | $2,057,535 | $334,509 |
| 2023 | 1,296 | 4,353 | 75 | 1.61 | $2,002,347 | $355,970 |
| 2022 | 1,270 | 4,382 | 75 | 1.50 | $2,033,334 | $385,897 |
| 2021 | 1,409 | 4,418 | 75 | 1.48 | $1,953,355 | $394,771 |
| 2020 | 1,232 | 3,720 | 74 | 1.52 | $1,655,353 | $346,579 |
| 2019 | 1,180 | 3,933 | 73 | 1.40 | $1,766,369 | $360,705 |
| 2018 | 988 | 3,505 | 74 | 1.46 | $1,567,087 | $327,931 |
| 2017 | 804 | 2,656 | 74 | 1.45 | $1,074,746 | $237,780 |
| 2016 | 262 | 565 | 71 | 1.58 | $219,138 | $52,485 |
| 2015 | 79 | 128 | 69 | 2.30 | $34,078 | $7,270 |
| 2014 | 25 | 41 | 67 | 2.45 | $11,317 | $2,455 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 47 services
| Return visit (30+ min) | 478 | $58,968 | $94 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 100 | $40,404 | $404 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 101 | $20,010 | $196 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 121 | $19,632 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 94 | $16,730 | $100 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 29 | $14,923 | $403 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 99 | $14,888 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 99 | $14,794 | $145 |
| Critical care, first 30-74 minutes | 39 | $10,823 | $177 |
| New patient visit (45+ min) | 75 | $9,989 | $133 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 172 | $9,932 | $55 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 32 | $8,797 | $275 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 564 | $7,739 | $12 |
| Long return visit (40+ min) | 46 | $7,421 | $146 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,596 | $430 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 93 | $4,881 | $52 |
| Transitional care management services for problem of high complexity | 17 | $4,452 | $247 |
| Balloon dilation of single coronary artery or branch | 11 | $4,291 | $390 |
| External shock to heart to regulate heart beat | 38 | $4,097 | $89 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 63 | $3,671 | $58 |
| Short return visit | 65 | $3,557 | $50 |
| Ultrasound of heart with probe in esophagus, with report | 37 | $3,341 | $88 |
| Removal and replacement of single lead permanent pacemaker | 12 | $3,259 | $272 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 76 | $3,094 | $20 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 18 | $2,943 | $38 |
| Transitional care management services for problem of at least moderate complexity | 13 | $2,741 | $183 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 50 | $2,644 | $53 |
| Programming of dual lead pacemaker system | 25 | $2,577 | $66 |
| New patient visit (60+ min) | 13 | $2,500 | $192 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $2,418 | $220 |
| Short return visit (20+ min) | 29 | $2,310 | $75 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 30 | $2,291 | $76 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 52 | $2,260 | $22 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 35 | $2,051 | $59 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 188 | $1,996 | $10 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 23 | $1,658 | $30 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,601 | $107 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 17 | $1,574 | $21 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 70 | $1,485 | $21 |
| Insertion of heart rhythm monitor under skin | 16 | $1,078 | $67 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | 19 | $913 | $41 |
| Ultrasound of heart, follow-up | 26 | $633 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 37 | $559 | $15 |
| Heart rhythm recording of continous external ekg over 8-15 days | 45 | $488 | $11 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 22 | $439 | $20 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 11 | $128 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 38 | $100 | $3 |
2022: 44 services
| Return visit (30+ min) | 534 | $77,563 | $95 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 117 | $48,819 | $417 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 176 | $28,969 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 132 | $22,285 | $86 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 116 | $20,407 | $89 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 97 | $18,812 | $188 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 31 | $16,416 | $410 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 46 | $13,228 | $288 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 22 | $11,584 | $527 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $11,143 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 183 | $10,480 | $56 |
| Critical care, first 30-74 minutes | 28 | $7,951 | $185 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 464 | $6,143 | $11 |
| New patient visit (45+ min) | 51 | $6,023 | $118 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 84 | $5,321 | $63 |
| Long return visit (40+ min) | 30 | $4,591 | $148 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 65 | $3,953 | $60 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 44 | $3,532 | $78 |
| Injection, regadenoson, 0.1 mg | 19 | $3,358 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 50 | $2,879 | $56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 67 | $2,692 | $18 |
| Short return visit | 47 | $2,556 | $50 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 38 | $2,226 | $59 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,941 | $92 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 174 | $1,906 | $11 |
| External shock to heart to regulate heart beat | 20 | $1,874 | $89 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 46 | $1,855 | $20 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 23 | $1,679 | $28 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,601 | $114 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 65 | $1,412 | $22 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | 23 | $1,404 | $41 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 16 | $1,315 | $63 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 18 | $1,270 | $22 |
| Programming of dual lead pacemaker system | 13 | $1,139 | $67 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 17 | $1,104 | $20 |
| Hospital discharge day management, more than 30 minutes | 11 | $953 | $87 |
| Ultrasound of heart, follow-up | 35 | $820 | $21 |
| Insertion of heart rhythm monitor under skin | 11 | $784 | $71 |
| Heart rhythm recording of continous external ekg over 8-15 days | 45 | $596 | $13 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 18 | $385 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $323 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $239 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $222 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $54 | $3 |
2021: 39 services
| Return visit (30+ min) | 500 | $75,524 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 245 | $43,576 | $174 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 77 | $33,889 | $440 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 152 | $30,802 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 122 | $20,988 | $165 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 105 | $20,449 | $191 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 37 | $19,593 | $435 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 249 | $14,810 | $58 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 72 | $12,943 | $90 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 42 | $12,490 | $297 |
| Critical care, first 30-74 minutes | 34 | $10,683 | $184 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 18 | $9,528 | $529 |
| New patient visit (45+ min) | 64 | $8,068 | $126 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 126 | $7,966 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 441 | $6,189 | $12 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 62 | $3,884 | $61 |
| Long return visit (40+ min) | 20 | $3,833 | $160 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 96 | $3,583 | $23 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 44 | $3,489 | $79 |
| Transitional care management services for problem of at least moderate complexity | 18 | $3,132 | $174 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 62 | $2,477 | $25 |
| Injection, regadenoson, 0.1 mg | 13 | $2,475 | None |
| External shock to heart to regulate heart beat | 24 | $2,432 | $90 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 65 | $2,047 | $31 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 180 | $2,012 | $11 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $1,961 | $93 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 28 | $1,791 | $24 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 34 | $1,763 | $32 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 27 | $1,644 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 25 | $1,432 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,388 | $116 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 51 | $1,199 | $23 |
| Ultrasound of heart, follow-up | 46 | $1,114 | $22 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 16 | $1,010 | $63 |
| Programming of dual lead pacemaker system | 11 | $840 | $65 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | 17 | $793 | $44 |
| Heart rhythm recording of continous external ekg over 8-15 days | 38 | $496 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $312 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $57 | $3 |
2020: 39 services
| Return visit (30+ min) | 449 | $65,067 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 244 | $41,688 | $169 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 70 | $30,445 | $429 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 136 | $27,802 | $89 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 90 | $18,917 | $201 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $16,722 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 247 | $15,049 | $60 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 24 | $13,432 | $537 |
| Critical care, first 30-74 minutes | 36 | $11,732 | $192 |
| New patient visit (45+ min) | 82 | $10,222 | $125 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 143 | $9,327 | $64 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | $9,140 | $435 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 28 | $8,609 | $307 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 395 | $6,216 | $13 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 18 | $3,192 | $89 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 47 | $3,101 | $62 |
| Long return visit (40+ min) | 26 | $2,945 | $113 |
| Transitional care management services for problem of at least moderate complexity | 17 | $2,770 | $163 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,694 | $117 |
| Transitional care management services for problem of high complexity | 11 | $2,369 | $215 |
| Injection, regadenoson, 0.1 mg | 12 | $2,239 | None |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 13 | $2,207 | $85 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 24 | $1,997 | $80 |
| Telephone medical discussion with physician, 21-30 minutes | 20 | $1,744 | $87 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 141 | $1,588 | $10 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,517 | $89 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 65 | $1,490 | $23 |
| External ekg recording for more than 48 hours up to 21 days | 56 | $1,369 | $24 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,208 | $93 |
| Ultrasound of heart, follow-up | 11 | $1,168 | $78 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 22 | $1,158 | $53 |
| Ultrasound of heart, follow-up | 45 | $1,030 | $22 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $939 | $67 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 11 | $892 | $64 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | 17 | $800 | $44 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 41 | $451 | $11 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 12 | $306 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $239 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $42 | $3 |
2019: 36 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 132 | $56,549 | $428 |
| Return visit (30+ min) | 386 | $50,596 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 123 | $23,443 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 136 | $23,266 | $171 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 112 | $22,170 | $196 |
| New patient visit (45+ min) | 155 | $17,817 | $115 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 88 | $15,530 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 89 | $14,980 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 235 | $14,571 | $60 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 29 | $14,341 | $448 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 141 | $9,033 | $64 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 16 | $8,521 | $533 |
| Critical care, first 30-74 minutes | 34 | $8,300 | $184 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 41 | $7,776 | $97 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 449 | $7,077 | $13 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 19 | $5,770 | $304 |
| Injection, regadenoson, 0.1 mg | 26 | $4,769 | None |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 54 | $3,542 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 58 | $3,118 | $54 |
| Transitional care management services for problem of at least moderate complexity | 23 | $3,118 | $136 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $2,783 | $253 |
| Long return visit (40+ min) | 20 | $2,706 | $118 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 171 | $1,823 | $10 |
| External ekg recording for more than 48 hours up to 21 days | 74 | $1,659 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 74 | $1,641 | $22 |
| External shock to heart to regulate heart beat | 16 | $1,588 | $88 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | 21 | $1,314 | $53 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,296 | $86 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 15 | $1,275 | $80 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 23 | $1,217 | $21 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $948 | $34 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 11 | $697 | $24 |
| Ultrasound of heart, follow-up | 21 | $458 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $234 | $15 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 13 | $153 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $41 | $3 |
2018: 33 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 118 | $49,853 | $422 |
| Return visit (30+ min) | 326 | $47,460 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 174 | $28,894 | $164 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 104 | $21,147 | $200 |
| New patient visit (45+ min) | 168 | $20,846 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 105 | $18,083 | $166 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 95 | $15,052 | $87 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 27 | $14,368 | $532 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $14,006 | $84 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 211 | $12,175 | $57 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 22 | $10,383 | $433 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $8,003 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 366 | $5,677 | $14 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 82 | $5,137 | $63 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 16 | $4,715 | $295 |
| Injection, regadenoson, 0.1 mg | 26 | $4,448 | None |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 55 | $4,233 | $77 |
| Transitional care management services for problem of high complexity | 18 | $3,711 | $195 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 22 | $2,958 | $95 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 38 | $1,953 | $51 |
| External ekg recording for more than 48 hours up to 21 days | 74 | $1,688 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 153 | $1,685 | $10 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $1,663 | $139 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 73 | $1,623 | $22 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,537 | $90 |
| Long return visit (40+ min) | 15 | $1,519 | $101 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, each additional vessel | 19 | $1,423 | $62 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 17 | $1,313 | $77 |
| Hospital discharge day management, more than 30 minutes | 11 | $980 | $89 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 14 | $607 | $22 |
| Ultrasound of heart, follow-up | 14 | $340 | $21 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $259 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $45 | $3 |
2017: 29 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 143 | $27,697 | $188 |
| New patient visit (45+ min) | 209 | $23,917 | $114 |
| Return visit (30+ min) | 189 | $23,791 | $84 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 47 | $19,647 | $418 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 124 | $15,676 | $58 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 77 | $14,852 | $183 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 25 | $13,341 | $534 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 208 | $10,988 | $51 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 22 | $10,920 | $420 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $8,571 | $162 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 46 | $7,974 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 58 | $7,220 | $103 |
| Short return visit (20+ min) | 93 | $6,465 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 285 | $4,366 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $3,907 | $85 |
| Injection, regadenoson, 0.1 mg | 18 | $2,921 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $2,771 | $231 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 26 | $2,236 | $77 |
| Long return visit (40+ min) | 17 | $1,908 | $112 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 29 | $1,882 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 32 | $1,790 | $56 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,259 | $90 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 101 | $1,051 | $10 |
| External ekg recording for more than 48 hours up to 21 days | 42 | $1,018 | $21 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 12 | $1,002 | $77 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 44 | $994 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $212 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $183 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $37 | $3 |
2016: 14 services
| New patient visit (45+ min) | 74 | $9,420 | $127 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 50 | $9,089 | $182 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $4,932 | $205 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,777 | $163 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 36 | $1,880 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,799 | $56 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $1,795 | $163 |
| Return visit (30+ min) | 20 | $1,688 | $84 |
| New patient visit (30+ min) | 19 | $1,680 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 112 | $1,632 | $14 |
| Short return visit (20+ min) | 18 | $1,019 | $57 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 13 | $255 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $110 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $72 | $7 |
2015: 5 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 12 | $1,963 | $164 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $187 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $169 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $110 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $75 | $6 |
Medicaid work
$10,705 in 2024
Medicaid paid $10,705 for 355 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 147 | $3,760 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 96 | $3,589 |
| Return visit (30+ min) | 51 | $1,181 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 20 | $927 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 27 | $723 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 14 | $524 |
| 2024 | 355 | 6 | 25 | $10,705 |
| 2023 | 441 | 4 | 24 | $19,650 |
| 2022 | 527 | 5 | 23 | $26,311 |
| 2021 | 642 | 4 | 35 | $33,473 |
| 2020 | 375 | 4 | 24 | $21,267 |
| 2019 | 152 | 3 | 21 | $9,633 |
| 2018 | 149 | 3 | 22 | $10,318 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 137 | $11,053 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 171 | $4,444 |
| Return visit (30+ min) | 111 | $3,604 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 22 | $550 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 165 | $14,686 |
| Return visit (30+ min) | 181 | $5,639 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 69 | $3,261 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 100 | $2,275 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 12 | $450 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 234 | $20,971 |
| Return visit (30+ min) | 194 | $6,320 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 141 | $3,787 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 73 | $2,395 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 190 | $15,733 |
| Return visit (30+ min) | 94 | $3,337 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 42 | $1,185 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 49 | $1,012 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 75 | $6,763 |
| Return visit (30+ min) | 37 | $2,341 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 40 | $529 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 62 | $6,821 |
| Return visit (30+ min) | 45 | $2,930 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 42 | $567 |
Drugs they prescribed that Part D paid
$2,155,740
Pharmacies billed $2,155,740 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 7,375) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
5,384 generic and 1,991 brand-name prescriptions · $2,155,740 in drug cost · 41 antibiotic prescriptions to 34 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 566 | $656,846 | $1,161 |
| Entresto | 617 | $602,614 | $977 |
| Farxiga | 219 | $236,196 | $1,079 |
| Jardiance | 158 | $186,276 | $1,179 |
| Repatha Sureclick | 108 | $119,065 | $1,102 |
See all 56 drugs
| Eliquis | 566 | $656,846 | $1,161 |
| Entresto | 617 | $602,614 | $977 |
| Farxiga | 219 | $236,196 | $1,079 |
| Jardiance | 158 | $186,276 | $1,179 |
| Repatha Sureclick | 108 | $119,065 | $1,102 |
| Xarelto | 102 | $117,423 | $1,151 |
| Nexlizet | 49 | $31,736 | $648 |
| Brilinta | 49 | $30,798 | $629 |
| Praluent | 24 | $28,743 | $1,198 |
| Wegovy | 11 | $19,335 | $1,758 |
| Atorvastatin | 1,066 | $11,753 | $11 |
| Dapagliflozin | 15 | $11,148 | $743 |
| Dofetilide | 31 | $6,626 | $214 |
| Metoprolol | 514 | $6,286 | $12 |
| Rosuvastatin | 312 | $6,028 | $19 |
| Clopidogrel | 373 | $5,146 | $14 |
| Ezetimibe | 128 | $4,620 | $36 |
| Bumetanide | 70 | $3,769 | $54 |
| Eplerenone | 38 | $3,551 | $93 |
| Losartan | 331 | $3,204 | $10 |
| Prasugrel | 23 | $2,481 | $108 |
| Amlodipine Besylate | 270 | $2,409 | $9 |
| Spironolactone | 232 | $2,194 | $9 |
| Isosorbide Mononitrate Er | 100 | $2,154 | $22 |
| Diltiazem 24hr Er (Cd) | 71 | $1,962 | $28 |
| Lisinopril | 224 | $1,917 | $9 |
| Celecoxib | 14 | $1,838 | $131 |
| Sotalol | 86 | $1,640 | $19 |
| Carvedilol | 169 | $1,594 | $9 |
| Pravastatin | 89 | $1,452 | $16 |
| Fenofibrate | 35 | $1,357 | $39 |
| Metoprolol | 128 | $1,331 | $10 |
| Amiodarone | 36 | $1,114 | $31 |
| Nitroglycerin | 92 | $1,045 | $11 |
| Furosemide | 154 | $1,015 | $7 |
| Losartan-Hydrochlorothiazide | 67 | $1,012 | $15 |
| Flecainide Acetate | 33 | $987 | $30 |
| Warfarin | 64 | $941 | $15 |
| Benazepril | 46 | $898 | $20 |
| Propranolol Hcl Er | 12 | $898 | $75 |
| Potassium Chloride | 59 | $849 | $14 |
| Cartia Xt | 19 | $660 | $35 |
| Atenolol | 38 | $649 | $17 |
| Verapamil Er | 14 | $469 | $34 |
| Valsartan | 20 | $463 | $23 |
| Hydrochlorothiazide | 106 | $456 | $4 |
| Sotalol Af | 22 | $430 | $20 |
| Propranolol | 12 | $326 | $27 |
| Digoxin | 16 | $318 | $20 |
| Pantoprazole | 24 | $284 | $12 |
| Olmesartan Medoxomil | 14 | $255 | $18 |
| Doxycycline Hyclate | 20 | $211 | $11 |
| Diltiazem | 16 | $206 | $13 |
| Torsemide | 13 | $186 | $14 |
| Hydralazine | 28 | $172 | $6 |
| Amoxicillin | 17 | $42 | $2 |
Year by year
| 2024 | 7,375 | 1,006 | 0% (0) | 27% | $2,155,740 |
| 2023 | 6,280 | 853 | 0% (0) | 22% | $1,619,999 |
| 2022 | 5,628 | 760 | 0% (0) | 18% | $1,074,307 |
| 2021 | 5,161 | 706 | 0% (0) | 19% | $754,322 |
| 2020 | 4,759 | 583 | None | 18% | $521,078 |
| 2019 | 4,052 | 545 | 0% (0) | 16% | $365,143 |
| 2018 | 2,998 | 422 | 0% (0) | 16% | $214,762 |
| 2017 | 1,895 | 306 | 0% (0) | 24% | $98,206 |
| 2016 | 759 | 221 | None | 40% | $32,647 |
| 2015 | 460 | 139 | None | 38% | $19,078 |
| 2014 | 221 | 70 | None | 17% | $8,004 |
| 2013 | 75 | 20 | None | None | $2,371 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 51 drugs
| Eliquis | 427 | $477,889 | $1,119 |
| Entresto | 410 | $415,285 | $1,013 |
| Jardiance | 113 | $138,891 | $1,229 |
| Farxiga | 112 | $123,376 | $1,102 |
| Xarelto | 73 | $108,439 | $1,485 |
| Repatha Sureclick | 94 | $103,348 | $1,099 |
| Praluent | 26 | $35,817 | $1,378 |
| Brilinta | 33 | $31,522 | $955 |
| Nexlizet | 23 | $22,764 | $990 |
| Atorvastatin | 933 | $15,770 | $17 |
| Dofetilide | 25 | $10,320 | $413 |
| Metoprolol | 481 | $8,355 | $17 |
| Rosuvastatin | 255 | $7,840 | $31 |
| Bumetanide | 76 | $7,773 | $102 |
| Icosapent Ethyl | 17 | $6,762 | $398 |
| Clopidogrel | 263 | $5,467 | $21 |
| Losartan | 328 | $5,034 | $15 |
| Savaysa | 11 | $4,753 | $432 |
| Diltiazem 24hr Er (Cd) | 83 | $3,937 | $47 |
| Ezetimibe | 80 | $3,899 | $49 |
| Spironolactone | 258 | $3,304 | $13 |
| Lisinopril | 230 | $3,206 | $14 |
| Isosorbide Mononitrate Er | 110 | $3,192 | $29 |
| Potassium Chloride | 86 | $3,154 | $37 |
| Warfarin | 113 | $3,084 | $27 |
| Amlodipine Besylate | 243 | $2,859 | $12 |
| Eplerenone | 17 | $2,682 | $158 |
| Sotalol | 70 | $2,451 | $35 |
| Flecainide Acetate | 31 | $2,350 | $76 |
| Fenofibrate | 26 | $2,243 | $86 |
| Prasugrel | 28 | $2,127 | $76 |
| Pravastatin | 94 | $2,001 | $21 |
| Nitroglycerin | 97 | $1,951 | $20 |
| Carvedilol | 132 | $1,907 | $14 |
| Furosemide | 157 | $1,219 | $8 |
| Diltiazem 24hr Er (Xr) | 16 | $1,193 | $75 |
| Losartan-Hydrochlorothiazide | 35 | $1,053 | $30 |
| Metoprolol | 114 | $1,019 | $9 |
| Valsartan | 14 | $976 | $70 |
| Propranolol Hcl Er | 13 | $906 | $70 |
| Benazepril | 30 | $875 | $29 |
| Digoxin | 14 | $663 | $47 |
| Amiodarone | 28 | $598 | $21 |
| Atenolol | 28 | $429 | $15 |
| Hydrochlorothiazide | 91 | $388 | $4 |
| Pantoprazole | 21 | $335 | $16 |
| Hydralazine | 21 | $273 | $13 |
| Torsemide | 12 | $162 | $13 |
| Doxycycline Hyclate | 12 | $134 | $11 |
| Simvastatin | 19 | $133 | $7 |
| Lisinopril-Hydrochlorothiazide | 11 | $132 | $12 |
2022: 48 drugs
| Eliquis | 379 | $377,398 | $996 |
| Entresto | 280 | $278,108 | $993 |
| Repatha Sureclick | 72 | $68,906 | $957 |
| Xarelto | 45 | $63,254 | $1,406 |
| Jardiance | 41 | $54,528 | $1,330 |
| Brilinta | 40 | $27,217 | $680 |
| Farxiga | 17 | $16,624 | $978 |
| Nexlizet | 22 | $16,113 | $732 |
| Praluent | 15 | $14,767 | $984 |
| Bumetanide | 74 | $13,972 | $189 |
| Atorvastatin | 854 | $13,757 | $16 |
| Prasugrel | 34 | $12,734 | $375 |
| Rosuvastatin | 257 | $11,784 | $46 |
| Metoprolol | 414 | $7,908 | $19 |
| Warfarin | 163 | $4,449 | $27 |
| Diltiazem 24hr Er (Cd) | 73 | $4,422 | $61 |
| Clopidogrel | 205 | $4,249 | $21 |
| Vascepa | 11 | $4,200 | $382 |
| Losartan | 238 | $3,424 | $14 |
| Spironolactone | 244 | $2,972 | $12 |
| Isosorbide Mononitrate Er | 97 | $2,810 | $29 |
| Amlodipine Besylate | 263 | $2,703 | $10 |
| Ezetimibe | 44 | $2,599 | $59 |
| Eplerenone | 17 | $2,560 | $151 |
| Fenofibrate | 25 | $2,506 | $100 |
| Carvedilol | 144 | $2,437 | $17 |
| Potassium Chloride | 59 | $2,290 | $39 |
| Midodrine | 15 | $2,279 | $152 |
| Flecainide Acetate | 51 | $2,212 | $43 |
| Nitroglycerin | 99 | $2,142 | $22 |
| Lisinopril | 242 | $1,966 | $8 |
| Sotalol | 64 | $1,913 | $30 |
| Furosemide | 220 | $1,397 | $6 |
| Pravastatin | 81 | $1,133 | $14 |
| Amiodarone | 43 | $997 | $23 |
| Aspirin-Dipyridamole Er | 11 | $967 | $88 |
| Valsartan | 15 | $942 | $63 |
| Sotalol Af | 27 | $924 | $34 |
| Losartan-Hydrochlorothiazide | 33 | $909 | $28 |
| Metoprolol | 120 | $880 | $7 |
| Digoxin | 15 | $638 | $43 |
| Benazepril | 28 | $612 | $22 |
| Hydrochlorothiazide | 107 | $455 | $4 |
| Hydralazine | 15 | $356 | $24 |
| Atenolol | 32 | $342 | $11 |
| Propranolol | 15 | $329 | $22 |
| Simvastatin | 23 | $142 | $6 |
| Lisinopril-Hydrochlorothiazide | 13 | $127 | $10 |
2021: 44 drugs
| Eliquis | 356 | $295,875 | $831 |
| Entresto | 237 | $196,800 | $830 |
| Repatha Sureclick | 75 | $50,010 | $667 |
| Xarelto | 29 | $42,913 | $1,480 |
| Atorvastatin | 892 | $14,012 | $16 |
| Brilinta | 28 | $13,599 | $486 |
| Jardiance | 12 | $12,905 | $1,075 |
| Vascepa | 28 | $9,173 | $328 |
| Bumetanide | 57 | $8,310 | $146 |
| Rosuvastatin | 193 | $7,995 | $41 |
| Metoprolol | 395 | $7,855 | $20 |
| Diltiazem 24hr Er (Cd) | 70 | $6,027 | $86 |
| Prasugrel | 32 | $4,854 | $152 |
| Losartan | 200 | $3,725 | $19 |
| Isosorbide Mononitrate Er | 122 | $3,324 | $27 |
| Warfarin | 107 | $2,891 | $27 |
| Clopidogrel | 172 | $2,827 | $16 |
| Spironolactone | 233 | $2,682 | $12 |
| Enoxaparin | 19 | $2,434 | $128 |
| Amlodipine Besylate | 243 | $2,324 | $10 |
| Flecainide Acetate | 55 | $2,252 | $41 |
| Nitroglycerin | 89 | $2,091 | $23 |
| Lisinopril | 282 | $1,883 | $7 |
| Ezetimibe | 32 | $1,708 | $53 |
| Carvedilol | 117 | $1,639 | $14 |
| Sotalol | 60 | $1,427 | $24 |
| Amiodarone | 34 | $1,413 | $42 |
| Midodrine | 15 | $1,356 | $90 |
| Valsartan | 31 | $1,325 | $43 |
| Potassium Chloride | 51 | $1,320 | $26 |
| Furosemide | 207 | $1,310 | $6 |
| Fenofibrate | 15 | $1,226 | $82 |
| Pravastatin | 81 | $1,007 | $12 |
| Sotalol Af | 25 | $903 | $36 |
| Cartia Xt | 12 | $833 | $69 |
| Benazepril | 31 | $783 | $25 |
| Digoxin | 16 | $634 | $40 |
| Metoprolol | 103 | $594 | $6 |
| Losartan-Hydrochlorothiazide | 14 | $523 | $37 |
| Hydrochlorothiazide | 99 | $455 | $5 |
| Atenolol | 37 | $366 | $10 |
| Hydralazine | 19 | $309 | $16 |
| Lisinopril-Hydrochlorothiazide | 14 | $86 | $6 |
| Clonidine | 12 | $45 | $4 |
2020: 40 drugs
| Eliquis | 243 | $180,103 | $741 |
| Entresto | 197 | $151,515 | $769 |
| Xarelto | 28 | $30,577 | $1,092 |
| Repatha Sureclick | 33 | $25,709 | $779 |
| Brilinta | 42 | $24,918 | $593 |
| Atorvastatin | 856 | $12,500 | $15 |
| Metoprolol | 401 | $9,392 | $23 |
| Rosuvastatin | 173 | $7,311 | $42 |
| Bumetanide | 54 | $7,171 | $133 |
| Vascepa | 17 | $6,546 | $385 |
| Diltiazem 24hr Er (Cd) | 78 | $4,286 | $55 |
| Clopidogrel | 171 | $3,228 | $19 |
| Losartan | 192 | $2,774 | $14 |
| Isosorbide Mononitrate Er | 122 | $2,506 | $21 |
| Lisinopril | 313 | $2,024 | $6 |
| Furosemide | 252 | $1,759 | $7 |
| Amlodipine Besylate | 248 | $1,573 | $6 |
| Spironolactone | 179 | $1,463 | $8 |
| Ezetimibe | 32 | $1,458 | $46 |
| Amiodarone | 17 | $1,426 | $84 |
| Valsartan | 29 | $1,423 | $49 |
| Nitroglycerin | 79 | $1,352 | $17 |
| Prasugrel | 12 | $1,315 | $110 |
| Warfarin | 50 | $1,305 | $26 |
| Pravastatin | 95 | $1,236 | $13 |
| Carvedilol | 99 | $1,165 | $12 |
| Sotalol | 30 | $1,120 | $37 |
| Eplerenone | 16 | $979 | $61 |
| Potassium Chloride | 36 | $840 | $23 |
| Irbesartan | 17 | $765 | $45 |
| Benazepril | 45 | $729 | $16 |
| Hydrochlorothiazide | 151 | $597 | $4 |
| Metoprolol | 88 | $533 | $6 |
| Atenolol | 49 | $441 | $9 |
| Torsemide | 27 | $426 | $16 |
| Flecainide Acetate | 16 | $397 | $25 |
| Sotalol Af | 15 | $386 | $26 |
| Cartia Xt | 11 | $344 | $31 |
| Simvastatin | 24 | $257 | $11 |
| Pantoprazole | 18 | $134 | $7 |
2019: 40 drugs
| Eliquis | 180 | $131,736 | $732 |
| Entresto | 83 | $60,452 | $728 |
| Xarelto | 38 | $32,838 | $864 |
| Brilinta | 58 | $27,215 | $469 |
| Atorvastatin | 747 | $12,279 | $16 |
| Praluent | 17 | $10,864 | $639 |
| Metoprolol | 414 | $9,813 | $24 |
| Rosuvastatin | 87 | $5,395 | $62 |
| Diltiazem 24hr Er (Cd) | 82 | $4,739 | $58 |
| Bumetanide | 22 | $4,526 | $206 |
| Amiodarone | 45 | $2,846 | $63 |
| Prasugrel | 22 | $2,540 | $115 |
| Clopidogrel | 156 | $2,201 | $14 |
| Isosorbide Mononitrate Er | 89 | $1,831 | $21 |
| Flecainide Acetate | 28 | $1,643 | $59 |
| Losartan | 124 | $1,590 | $13 |
| Lisinopril | 230 | $1,559 | $7 |
| Amlodipine Besylate | 198 | $1,535 | $8 |
| Pravastatin | 79 | $1,516 | $19 |
| Furosemide | 256 | $1,396 | $5 |
| Ezetimibe | 31 | $1,260 | $41 |
| Eplerenone | 14 | $1,122 | $80 |
| Carvedilol | 78 | $1,071 | $14 |
| Spironolactone | 128 | $1,019 | $8 |
| Sotalol | 24 | $1,007 | $42 |
| Benazepril | 65 | $909 | $14 |
| Warfarin | 42 | $901 | $21 |
| Nitroglycerin | 58 | $873 | $15 |
| Potassium Chloride | 44 | $859 | $20 |
| Cartia Xt | 16 | $656 | $41 |
| Atenolol | 51 | $624 | $12 |
| Metoprolol | 91 | $541 | $6 |
| Irbesartan | 13 | $517 | $40 |
| Hydrochlorothiazide | 128 | $512 | $4 |
| Propranolol | 13 | $500 | $38 |
| Bisoprolol | 12 | $451 | $38 |
| Lovastatin | 13 | $362 | $28 |
| Simvastatin | 49 | $338 | $7 |
| Torsemide | 18 | $298 | $17 |
| Trazodone | 12 | $80 | $7 |
2018: 36 drugs
| Eliquis | 94 | $59,498 | $633 |
| Brilinta | 77 | $34,838 | $452 |
| Xarelto | 26 | $21,422 | $824 |
| Entresto | 32 | $20,405 | $638 |
| Atorvastatin | 685 | $10,312 | $15 |
| Metoprolol | 308 | $7,203 | $23 |
| Prasugrel | 18 | $6,966 | $387 |
| Rosuvastatin | 37 | $3,328 | $90 |
| Tekturna | 11 | $3,162 | $287 |
| Pravastatin | 90 | $1,890 | $21 |
| Isosorbide Mononitrate Er | 62 | $1,411 | $23 |
| Clopidogrel | 108 | $1,365 | $13 |
| Diltiazem 24hr Er (Cd) | 28 | $1,300 | $46 |
| Amlodipine Besylate | 165 | $1,267 | $8 |
| Furosemide | 223 | $993 | $4 |
| Warfarin | 38 | $855 | $22 |
| Sotalol | 22 | $837 | $38 |
| Losartan | 73 | $831 | $11 |
| Benazepril | 66 | $741 | $11 |
| Lisinopril | 119 | $708 | $6 |
| Spironolactone | 85 | $696 | $8 |
| Ezetimibe | 13 | $682 | $52 |
| Nitroglycerin | 34 | $674 | $20 |
| Amiodarone | 15 | $573 | $38 |
| Flecainide Acetate | 11 | $535 | $49 |
| Carvedilol | 64 | $516 | $8 |
| Metoprolol | 84 | $503 | $6 |
| Valsartan | 13 | $433 | $33 |
| Cartia Xt | 16 | $406 | $25 |
| Potassium Chloride | 20 | $332 | $17 |
| Simvastatin | 48 | $322 | $7 |
| Hydrochlorothiazide | 73 | $284 | $4 |
| Torsemide | 17 | $204 | $12 |
| Irbesartan | 11 | $189 | $17 |
| Atenolol | 23 | $112 | $5 |
| Trazodone | 14 | $85 | $6 |
2017: 27 drugs
| Brilinta | 61 | $23,506 | $385 |
| Eliquis | 28 | $12,199 | $436 |
| Xarelto | 23 | $9,545 | $415 |
| Metoprolol | 189 | $5,828 | $31 |
| Atorvastatin | 415 | $5,722 | $14 |
| Tekturna | 12 | $3,052 | $254 |
| Diltiazem 24hr Er | 19 | $1,432 | $75 |
| Pravastatin | 50 | $1,015 | $20 |
| Rosuvastatin | 12 | $1,014 | $84 |
| Isosorbide Mononitrate Er | 55 | $853 | $16 |
| Amlodipine Besylate | 127 | $805 | $6 |
| Furosemide | 170 | $738 | $4 |
| Metoprolol | 78 | $555 | $7 |
| Spironolactone | 60 | $531 | $9 |
| Lisinopril | 74 | $481 | $6 |
| Propafenone | 11 | $457 | $42 |
| Warfarin | 44 | $441 | $10 |
| Valsartan-Hydrochlorothiazide | 18 | $407 | $23 |
| Losartan | 50 | $383 | $8 |
| Sotalol | 26 | $359 | $14 |
| Benazepril | 37 | $330 | $9 |
| Clopidogrel | 19 | $280 | $15 |
| Carvedilol | 42 | $266 | $6 |
| Amiodarone | 24 | $228 | $9 |
| Cartia Xt | 16 | $220 | $14 |
| Hydrochlorothiazide | 59 | $190 | $3 |
| Simvastatin | 16 | $88 | $6 |
2016: 15 drugs
| Pradaxa | 29 | $5,556 | $192 |
| Atorvastatin | 155 | $4,785 | $31 |
| Metoprolol | 32 | $2,003 | $63 |
| Isosorbide Mononitrate Er | 57 | $1,200 | $21 |
| Clopidogrel | 30 | $956 | $32 |
| Pravastatin | 19 | $848 | $45 |
| Furosemide | 71 | $648 | $9 |
| Metoprolol | 68 | $608 | $9 |
| Nitrostat | 12 | $500 | $42 |
| Amlodipine Besylate | 32 | $351 | $11 |
| Spironolactone | 33 | $325 | $10 |
| Lisinopril | 33 | $309 | $9 |
| Sotalol | 17 | $237 | $14 |
| Carvedilol | 22 | $226 | $10 |
| Hydrochlorothiazide | 13 | $59 | $5 |
2015: 12 drugs
| Atorvastatin | 62 | $2,245 | $36 |
| Isosorbide Mononitrate Er | 54 | $1,017 | $19 |
| Pravastatin | 23 | $910 | $40 |
| Clopidogrel | 20 | $604 | $30 |
| Furosemide | 45 | $438 | $10 |
| Metoprolol | 48 | $426 | $9 |
| Acetylcysteine | 11 | $289 | $26 |
| Sotalol | 15 | $257 | $17 |
| Simvastatin | 12 | $220 | $18 |
| Amlodipine Besylate | 15 | $218 | $15 |
| Carvedilol | 16 | $180 | $11 |
| Atenolol | 12 | $98 | $8 |
2014: 3 drugs
| Clopidogrel | 78 | $2,116 | $27 |
| Atorvastatin | 23 | $512 | $22 |
| Hydrochlorothiazide | 12 | $54 | $4 |
2013: 1 drug
| Clopidogrel | 32 | $1,264 | $40 |
Money from drug and device companies
$5,765 in 2025
| 2025 | 12 | 71 | None | $5,765 |
| 2024 | 10 | 27 | None | $894 |
| 2023 | 11 | 33 | None | $1,339 |
| 2022 | 12 | 50 | None | $3,976 |
| 2021 | 12 | 30 | None | $1,005 |
| 2020 | 15 | 39 | None | $706 |
| 2019 | 12 | 46 | None | $1,915 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Symplicity G3 | $4,808 | 46 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $299 | 10 payments
|
| Abbott Laboratories | Cardiomems | $221 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $112 | 1 payment
|
| Stryker | Flowtriever Catheter, S | $78 | 2 payments
|
| Pfizer | Vyndaqel | $52 | 2 payments
|
See all 71 published payments
| Medtronic | Meals · 2025-12-19 | Symplicity G3 | $114 |
| Abbott Laboratories | Meals · 2025-12-16 | Cardiomems | $166 |
| Edwards Lifesciences | Meals · 2025-12-09 | Sapien 3 Ultra Resilia | $47 |
| Boston Scientific | Meals · 2025-11-25 | Watchman Flx | $11 |
| Boston Scientific | Meals · 2025-10-30 | Watchman Flx | $11 |
| Medtronic | Meals · 2025-10-22 | Symplicity G3 | $24 |
| Pfizer | Meals · 2025-10-09 | Vyndaqel | $28 |
| Medtronic | Meals · 2025-10-06 | Symplicity G3 | $77 |
| Amgen | Meals · 2025-09-24 | None | $14 |
| Medtronic | Meals · 2025-09-19 | Symplicity G3 | $105 |
| Medtronic | Meals · 2025-09-19 | Symplicity G3 | $41 |
| Medtronic | Meals · 2025-09-19 | Symplicity G3 | $67 |
| Medtronic | Meals · 2025-09-18 | Symplicity G3 | $67 |
| Medtronic | Meals · 2025-09-18 | Symplicity G3 | $23 |
| Medtronic | Meals · 2025-09-18 | Symplicity G3 | $51 |
| Medtronic | Meals · 2025-09-18 | Symplicity G3 | $40 |
| Medtronic | Travel · 2025-09-18 | Symplicity G3 | $329 |
| Medtronic | Travel · 2025-09-18 | Symplicity G3 | $52 |
| Medtronic | Travel · 2025-09-15 | Symplicity G3 | $900 |
| Medtronic | Travel · 2025-09-15 | Symplicity G3 | $35 |
| Pfizer | Meals · 2025-08-08 | Vyndaqel | $24 |
| Abbott Laboratories | Meals · 2025-07-21 | Amplatzer Amulet | $27 |
| Boston Scientific | Meals · 2025-07-11 | Watchman Flx | $12 |
| Medtronic | Meals · 2025-07-10 | Symplicity G3 | $135 |
| Medtronic | Meals · 2025-07-10 | Symplicity G3 | $24 |
| Abiomed | Meals · 2025-07-09 | None | $37 |
| Boston Scientific | Meals · 2025-06-26 | Emblem Mri S-Icd | $17 |
| Medtronic | Travel · 2025-06-24 | Micra | $156 |
| Medtronic | Meals · 2025-06-22 | Micra | $20 |
| Medtronic | Travel · 2025-06-22 | Micra | $22 |
| Medtronic | Travel · 2025-06-21 | Micra | $156 |
| Medtronic | Travel · 2025-06-20 | None | $299 |
| Medtronic | Travel · 2025-06-20 | None | $84 |
| Medtronic | Meals · 2025-06-20 | None | $91 |
| Medtronic | Meals · 2025-06-20 | None | $136 |
| Medtronic | Meals · 2025-06-20 | None | $63 |
| Medtronic | Meals · 2025-06-20 | Micra | $33 |
| Medtronic | Meals · 2025-06-10 | Symplicity G3 | $23 |
| Medtronic | Travel · 2025-06-09 | None | $356 |
| Amgen | Meals · 2025-06-03 | None | $23 |
| Medtronic | Meals · 2025-05-28 | Symplicity G3 | $27 |
| Medtronic | Meals · 2025-05-27 | Micra | $52 |
| Abbott Laboratories | Meals · 2025-05-16 | Pressurewire | $27 |
| Stryker | Meals · 2025-04-29 | Flowtriever Catheter, S | $42 |
| Medtronic | Travel · 2025-04-21 | Ffrangio | $97 |
| Philips North America | Meals · 2025-04-18 | Mcot | $46 |
| Medtronic | Travel · 2025-04-11 | Ffrangio | $485 |
| Medtronic | Meals · 2025-04-11 | Ffrangio | $29 |
| Medtronic | Meals · 2025-04-10 | Ffrangio | $3 |
| Medtronic | Travel · 2025-04-10 | Ffrangio | $56 |
| Medtronic | Meals · 2025-04-10 | Ffrangio | $8 |
| Medtronic | Meals · 2025-04-10 | Onyx Frontier | $29 |
| Medtronic | Travel · 2025-04-02 | None | $150 |
| Medtronic | Travel · 2025-04-02 | None | $154 |
| Medtronic | Travel · 2025-04-02 | None | $35 |
| Medtronic | Travel · 2025-04-02 | None | $35 |
| Boston Scientific | Meals · 2025-04-01 | Lux-Dx Insertable Cardiac Monitor | $3 |
| Stryker | Meals · 2025-04-01 | Flowtriever Catheter, S | $36 |
| Medtronic | Meals · 2025-03-27 | Symplicity G3 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-03-18 | Lifevest | $6 |
| Boston Scientific | Meals · 2025-03-13 | Lux-Dx Insertable Cardiac Monitor | $25 |
| Medtronic | Meals · 2025-03-04 | Micra | $36 |
| Boston Scientific | Meals · 2025-02-28 | Watchman Flx | $9 |
| Boston Scientific | Meals · 2025-02-20 | General - Tachy | $115 |
| Medtronic | Meals · 2025-02-11 | Micra | $17 |
| Esperion Therapeutics | Meals · 2025-02-11 | Nexletol | $22 |
| Medtronic | Meals · 2025-02-06 | Symplicity G3 | $8 |
| Medtronic | Meals · 2025-02-05 | Micra | $41 |
| Boston Scientific | Meals · 2025-01-23 | Lux-Dx Insertable Cardiac Monitor | $16 |
| Boston Scientific | Meals · 2025-01-22 | Lux-Dx Insertable Cardiac Monitor | $81 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-07 | Jardiance | $112 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $894
| Abiomed | Impella | $192 | 3 payments
|
| Philips North America | (P84) Igt Devices Systems | $176 | 8 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $140 | 1 payment
|
| Medtronic | Ffrangio | $86 | 3 payments
|
| Heartflow | Ffrct | $72 | 2 payments
|
| Abbott Laboratories | Assurity | $71 | 2 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $69 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $42 | 4 payments
|
| Terumo Medical | Azur Cx Detachable | $28 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $18 | 1 payment
|
2023: $1,339
| Inari Medical | Flowtriever Catheter, S | $300 | 2 payments
|
| Boston Scientific | Watchman Flx | $201 | 6 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $195 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $187 | 4 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $145 | 11 payments
|
| HeartFlow | Ffrct | $94 | 1 payment
|
| Philips Electronics North America | (6571) Eagle Eye | $85 | 2 payments
|
| Medtronic | Onyx Frontier | $50 | 2 payments
|
| Abbott Laboratories | Cardiomems | $44 | 1 payment
|
| Esperion Therapeutics | Nexletol | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
2022: $3,976
| Medtronic | Advisa Dr Mri Surescan | $3,123 | 24 payments
|
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $202 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $179 | 1 payment
|
| Amgen | Repatha | $142 | 3 payments
|
| Abiomed | Impella | $68 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $55 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $54 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Andexxa | $38 | 2 payments
|
| HeartFlow | Ffrct | $34 | 1 payment
|
| Terumo Medical | Tr Band | $32 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $26 | 2 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $23 | 1 payment
|
2021: $1,005
| Abbott Laboratories | Cardiomems Hf System | $237 | 4 payments
|
| Philips Electronics North America | (6585) Omniwire | $231 | 7 payments
|
| Boston Scientific | Emblem | $146 | 4 payments
|
| Penumbra | Indigo System | $142 | 1 payment
|
| Abiomed | Impella | $46 | 2 payments
|
| HeartFlow | Ffrct | $41 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $37 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $32 | 1 payment
|
| Shockwave Medical | Vascular Lithotripsy | $30 | 2 payments
|
| Chiesi USA | Kengreal | $25 | 1 payment
|
| Medtronic | Telescope | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
2020: $706
| Abiomed | Impella | $114 | 5 payments
|
| Amarin Pharma | Vascepa | $113 | 12 payments
|
| Boston Scientific | Emblem | $88 | 2 payments
|
| Abbott Laboratories | Cardiomems Hf System | $71 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $61 | 3 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $46 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $38 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $37 | 2 payments
|
| Philips Electronics North America | Igt D Coronary | $29 | 1 payment
|
| Amgen | Repatha | $27 | 1 payment
|
| HeartFlow | None | $22 | 1 payment
|
| Preventice Services | None | $19 | 1 payment
|
| Acist Medical Systems | Cvi Systems | $17 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $14 | 1 payment
|
| Medtronic Vascular | Reveal Linq | $12 | 1 payment
|
2019: $1,915
| Abbott Laboratories | Mitra Clip System | $770 | 15 payments
|
| Medtronic Vascular | Corevalve Evolut | $445 | 10 payments
|
| Abiomed | Legacy | $155 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $147 | 4 payments
|
| Amgen | Repatha | $116 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $111 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $47 | 3 payments
|
| Terumo Medical | Glidesheath | $42 | 2 payments
|
| Acist Medical Systems | Cvi Consumables | $30 | 2 payments
|
| Regeneron Healthcare Solutions | Praluent | $20 | 1 payment
|
| Boston Scientific | Watchman | $18 | 1 payment
|
| iRhythm Technologies | Zio Patch | $14 | 1 payment
|
Professional record
- NPI
- 1750561973
- Licence
- CA A105376California A105376: Current · expires 2026-09-30
- Trained
- Boston University School of Medicine, 2007
- Group
- Sutter Bay Medical Foundation · Sutter Bay Hospitals
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 34 Mark West Springs Rd Ste 310, Santa Rosa, CA, 95403
- NPI first listed
- 2007-11-05
- NPI last updated
- 2018-11-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3288 Moanalua Rd, Honolulu, HI, 96819